Investors
About Nephros, Inc.
Nephros, Inc. became a Delaware corporation on April 3, 1997
Nephros is a company committed to improving the human relationship with water through leading, accessible technology. We provide innovative water filtration products and services, along with water-quality education, as part of an integrated approach to water safety. Nephros goods serve the needs of customers within the healthcare and commercial markets, offering both proactive and emergency solutions for water management.
As a 2019 and 2020 Deloitte “Fast 500” biotechnology company (2019 and 2020) publicly traded on the Nasdaq (Nasdaq: NEPH), we continuously demonstrate consistently high revenue growth and product innovation. Our leading water filtration and testing science, education, and outstanding customer support represent a comprehensive, integrated approach to water safety. While we are most known for our FDA-cleared infection control water filters, we acquired Aether Water Systems to deliver more complete and integrated turnkey solutions to our customers. Our commitment to enhanced engineering, research and development, and quality control position our filtration technology to be arguably the gold standard.
NASDAQ Stock Symbol: NEPH
CUSIP: 640671400
Headquarters:
380 Lackawanna Place
South Orange, NJ 07079
Transfer Agent:
Vstock Transfer, LLC
18 Lafayette Place
Woodmere, NY 11598
Phone: (212) 828-8436
Toll-Free: (855) 9VSTOCK
Fax: (646) 536-3179
Email: info@vstocktransfer.com
For help transferring a share certificate into a trust or another name, replacing a lost share certification, or to setup online deliveries of shareholder materials:
Looking for more information?
Meet the Nephros Board of Directors, responsible for assessing the overall direction and strategy for how we improve the human relationship with water.
Joe Harris
Joe is currently the Midwest, Sales Director at Murj. Previous positions have included East, Areas Sales Director at HeartFlow, Inc.,…
Tom Gwydir
Tom is currently Chief Information Officer (CIO) at the London Stock Exchange. Prior positions have included CIO and Chief Technology…
Alisa Lask
Alisa brings more than 20 years of commercial experience in sales and marketing across pharmaceutical, medical device, and cosmeceutical sectors….
Oliver Spandow
Oliver is currently the Chief Financial Officer, Executive Vice President and a member of the board of directors of IDOC,…
Arthur Amron
Arthur is a partner of Wexford Capital and serves as its General Counsel. He actively participates in various private equity…
Andy Astor
An entrepreneurial technology executive with over 35 years of operating and financial experience, Andy Astor was named Chief Executive Officer…
